329 related articles for article (PubMed ID: 2250044)
1. Monoclonal antibody 425 inhibits growth stimulation of carcinoma cells by exogenous EGF and tumor-derived EGF/TGF-alpha.
Rodeck U; Williams N; Murthy U; Herlyn M
J Cell Biochem; 1990 Oct; 44(2):69-79. PubMed ID: 2250044
[TBL] [Abstract][Full Text] [Related]
2. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
Fan Z; Masui H; Altas I; Mendelsohn J
Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
[TBL] [Abstract][Full Text] [Related]
3. Autonomous growth of human keratinocytes requires epidermal growth factor receptor occupancy.
Pittelkow MR; Cook PW; Shipley GD; Derynck R; Coffey RJ
Cell Growth Differ; 1993 Jun; 4(6):513-21. PubMed ID: 8373735
[TBL] [Abstract][Full Text] [Related]
4. Growth regulation of human renal carcinoma cells: role of transforming growth factor alpha.
Atlas I; Mendelsohn J; Baselga J; Fair WR; Masui H; Kumar R
Cancer Res; 1992 Jun; 52(12):3335-9. PubMed ID: 1596891
[TBL] [Abstract][Full Text] [Related]
5. Involvement of transforming growth factor alpha/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vitro.
Morishige K; Kurachi H; Amemiya K; Adachi H; Inoue M; Miyake A; Tanizawa O; Sakoyama Y
Cancer Res; 1991 Nov; 51(21):5951-5. PubMed ID: 1718591
[TBL] [Abstract][Full Text] [Related]
6. Effect of epidermal growth factor/transforming growth factor alpha and transforming growth factor beta 1 on growth in vitro of rat urinary bladder carcinoma cells.
Kawamata H; Azuma M; Kameyama S; Nan L; Oyasu R
Cell Growth Differ; 1992 Nov; 3(11):819-25. PubMed ID: 1467309
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of epidermal growth factor/transforming growth factor-alpha-stimulated cell growth by a synthetic peptide.
Eppstein DA; Marsh YV; Schryver BB; Bertics PJ
J Cell Physiol; 1989 Nov; 141(2):420-30. PubMed ID: 2530243
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-alpha acts as an autocrine growth factor in ovarian carcinoma cell lines.
Stromberg K; Collins TJ; Gordon AW; Jackson CL; Johnson GR
Cancer Res; 1992 Jan; 52(2):341-7. PubMed ID: 1309440
[TBL] [Abstract][Full Text] [Related]
9. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
Ethier SP; Langton BC; Dilts CA
Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies.
Mendelsohn J
J Natl Cancer Inst Monogr; 1992; (13):125-31. PubMed ID: 1389685
[TBL] [Abstract][Full Text] [Related]
11. Heparin inhibition of autonomous growth implicates amphiregulin as an autocrine growth factor for normal human mammary epithelial cells.
Li S; Plowman GD; Buckley SD; Shipley GD
J Cell Physiol; 1992 Oct; 153(1):103-11. PubMed ID: 1522124
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins.
Gong Y; Anzai Y; Murphy LC; Ballejo G; Holinka CF; Gurpide E; Murphy LJ
Cancer Res; 1991 Oct; 51(20):5476-81. PubMed ID: 1833051
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of epidermal growth factor and insulin-like growth factor-I receptors and autocrine stimulation in human esophageal carcinoma cells.
Chen SC; Chou CK; Wong FH; Chang CM; Hu CP
Cancer Res; 1991 Apr; 51(7):1898-903. PubMed ID: 2004373
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids coordinately disrupt a transforming growth factor alpha autocrine loop and suppress the growth of 13762NF-derived Con8 rat mammary adenocarcinoma cells.
Alexander DB; Goya L; Webster MK; Haraguchi T; Firestone GL
Cancer Res; 1993 Apr; 53(8):1808-15. PubMed ID: 8467499
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor dependence and TGF alpha autocrine growth regulation in primary rat tracheal epithelial cells.
Ferriola PC; Robertson AT; Rusnak DW; Diaugustine R; Nettesheim P
J Cell Physiol; 1992 Aug; 152(2):302-9. PubMed ID: 1639864
[TBL] [Abstract][Full Text] [Related]
16. Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha.
Reddy CC; Wells A; Lauffenburger DA
J Cell Physiol; 1996 Mar; 166(3):512-22. PubMed ID: 8600155
[TBL] [Abstract][Full Text] [Related]
17. Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor alpha.
Hofer DR; Sherwood ER; Bromberg WD; Mendelsohn J; Lee C; Kozlowski JM
Cancer Res; 1991 Jun; 51(11):2780-5. PubMed ID: 2032218
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-alpha secretion by epidermal growth factor-dependent human tumor cell lines.
Singletary SE; Williams NN; Rodeck U; Larry L; Tucker S; Spitzer G; Herlyn M
Anticancer Res; 1990; 10(6):1501-5. PubMed ID: 2285223
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-alpha and insulin-like growth factor-I, but not epidermal growth factor, elicit autocrine stimulation of mitogenesis in endometrial cancer cell lines.
Reynolds RK; Hu C; Baker VV
Gynecol Oncol; 1998 Aug; 70(2):202-9. PubMed ID: 9740691
[TBL] [Abstract][Full Text] [Related]
20. EGF, TGF alpha, AR and HB-EGF are autocrine growth factors for human bladder carcinoma cell lines.
Ruck A; Paulie S
Anticancer Res; 1998; 18(3A):1447-52. PubMed ID: 9673354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
